Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Access Pharmaceuticals Inc

+ Add to Watchlist

ACCP:US

0.5300 USD 0.0110 2.12%

As of 20:10:00 ET on 05/24/2013.

Company Profile for Access Pharmaceuticals Inc (ACCP)

Access Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops products for the treatment and supportive care of cancer patients.

Contact Information

Access Pharmaceuticals Inc

2600 Stemmons Freeway
Suite 176
Dallas, TX 75207
United States
Phone: 1-214-905-5100
Fax: 1-214-905-5101

Key Executives for Access Pharmaceuticals Inc (ACCP)

Jeffrey B DavisPresident/CEODavid P NowotnikSenior VP:Research & Dev
Stephen B ThompsonVP/CFO/Treasurer/SecretaryFrank A JacobucciVP:Sales & Marketing

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil